Quanterix shares are trading higher after the company announced a new agreement with Janssen Sciences Ireland UC to advance blood based Alzheimer's Disease detection.
Portfolio Pulse from Benzinga Newsdesk
Quanterix has announced a new agreement with Janssen Sciences Ireland UC to advance blood based Alzheimer's Disease detection. This news has led to an increase in Quanterix's share price.
October 24, 2023 | 3:19 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Quanterix's new agreement with Janssen Sciences Ireland UC for Alzheimer's Disease detection has led to a rise in its share price.
The new agreement with Janssen Sciences Ireland UC is a positive development for Quanterix, as it could potentially lead to advancements in Alzheimer's Disease detection. This news has been positively received by the market, leading to an increase in Quanterix's share price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100